Successful proof of concept with imsus platform technology: Preclinical development of a 1-month controlled release formulation for a peptide drug


    loading  Checking for direct PDF access through Ovid

Abstract

Microparticle-based controlled release formulations of a peptide drug for subcutaneous application were manufactured by means of ALRISE's innovative proprietary ImSus platform technology, delivering reproducible and scalable batches. Analytical data and in-vivo release profiles in rats showed promising results.

    loading  Loading Related Articles